News search

E.g., 14/06/2025
E.g., 14/06/2025
De izquierda a derecha y de arriba hacia abajo: Maria Rosaria Pricolo, Natalia Vicente, Verónica Labrador, Olga Giménez, Manuel Gavilán, Jon Sicilia, Jesús Vázquez, Elías Herrero, Roberto Silva, Jorge Alegre y Diana Velázquez.
Research
5 Jun 2025

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

Sarai Martínez Cano, Marcos Femenía Muiña, Elena Hernández, Vanessa Núñez, Manuel Rodrigo Tapias, Miguel Galán Burgos, Iñaki Robles,  Alberto Benguria, David Sancho y Almudena Ramiro
Research
2 Jun 2025

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Jorge Nicolás Domínguez, Susana Temiño, Morena Raiola, Miquel Sendra y Miguel Torres.
Research
29 May 2025

CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering.

Jianyi «Jay» Zhang
Research
14 May 2025

Jianyi «Jay» Zhang,  Chair of the Department of Biomedical Engineering (BME), at University of Alabama -Birmingham (UAB).

Dr. Benjamin L. Prosser
Research
7 May 2025

Dr. Benjamin L. Prosser is an Associate Professor in the Department of Physiology at the Perelman School of Medicine at the University of Pennsylvania.

José Javier Fuster and Daniel Ketelhuth
Research
28 Apr 2025

Prof. Daniel Ketelhuth leads a research team at the University of Southern Denmark

David Sancho, Ignacio Heras-Murillo y Stefanie Wculek.
Research
14 Apr 2025

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer

Juan Pablo Ochoa, Pablo García-Pavía, Laura Lalaguna, Marina López-Olañeta, María Arévalo-Núñez de Arenas y Enrique Lara-Pezzi.
Research
9 Apr 2025

A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men

Proyecto_CARMINA
About the CNIC
8 Apr 2025

The system provides specialised answers to biomedical questions, ensuring data privacy by operating exclusively within the CNIC

Dr. Giuseppe Danilo Norata
About the CNIC
3 Apr 2025

Dr. Giuseppe Danilo Norata is a Full Professor of Pharmacology at the Department of Excellence of Pharmacological and Biomolecular Sciences, University of Milan